Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220006769 220002601 0 null Disease modification (D) 2016-01-14 2016-01-14 Nilotinib N N 220030998 NILOTINIB
220006770 220002602 1.86 74.8 Curative (C) 2015-06-09 2015-06-09 AML 19 TRIAL Y N 220031000 AML19 TRIAL
220006771 220002602 1.8 69.5 Curative (C) 2014-01-06 2014-01-07 AML 19 TRIAL N N 220031000 AML19 TRIAL
220006772 220002603 1.85 68.7 Curative (C) 2013-04-19 2013-04-19 AML 19 TRIAL 01 N 220031002 AML19 TRIAL
220006773 220002603 1.62 75 Curative (C) 2017-10-29 2017-10-30 FLAG + Idarubicin N N 220031002 FLAG + IDARUBICIN
220006774 220002604 1.74 null null null 2015-07-03 AML 19 TRIAL 01 Y 220031004 AML19 TRIAL
220006775 220002605 0 null null 2016-08-04 2016-08-06 Nilotinib N N 220031013 NILOTINIB
220006776 220002605 1.55 52.6 Curative (C) 2015-11-21 2015-11-23 AML 19 TRIAL Y N 220031013 AML19 TRIAL
220006777 220002605 1.54 58.4 Curative (C) 2013-12-20 2013-12-20 AML 19 TRIAL Y N 220031013 AML19 TRIAL
220006778 220002605 0 0 Unknown (U) null 2017-01-06 Nilotinib N N 220031013 NILOTINIB
220006779 220002605 null 63.4 Curative (C) 2015-05-27 2015-05-27 FLAG + Idarubicin 01 N 220031013 FLAG + IDARUBICIN
220006780 220002606 1.78 0 Curative (C) 2017-05-18 2017-05-19 Nilotinib N N 220031027 NILOTINIB
220006781 220002607 1.55 73.6 Curative (C) 2016-05-26 2016-05-26 AML 19 TRIAL Y null 220031028 AML19 TRIAL
220006782 220002607 null 84.6 Curative (C) 2018-07-13 2018-07-13 FLAG + Idarubicin 02 N 220031028 FLAG + IDARUBICIN
220006783 220002608 1.57 70.2 Curative (C) 2017-10-27 2017-10-27 null N N 220031030 NOT MATCHED
220006784 220002608 1.62 null Curative (C) 2016-02-17 2016-02-18 FLAG + Idarubicin N null 220031030 FLAG + IDARUBICIN
220006785 220002608 0 83.5 null 2015-03-14 2015-12-28 Nilotinib N N 220031030 NILOTINIB
220006786 220002608 null 0 Palliative (P) 2017-03-06 2017-03-06 Nilotinib 02 N 220031030 NILOTINIB
220006787 220002609 null 56.9 null 2014-03-30 2014-05-18 Cisplatin + Gemcitabine (D 1 & 8) N N 220031043 CISPLATIN + GEMCITABINE
220006788 220002610 1.6 71.6 Palliative (P) 2014-10-30 2014-11-03 CISPLATIN + GEMCITABINE 2 N 220031044 CISPLATIN + GEMCITABINE
220006789 220011514 1.52 null Curative (C) null 2013-08-31 AML 18 TRIAL Y N 220031045 AML18 TRIAL
220006790 220002611 1.65 65 Curative (C) 2015-07-20 2015-07-26 AML16 DA 3+10 N N 220031046 AML16 TRIAL
220006791 220002611 1.59 111.5 Palliative (P) 2017-07-12 2017-08-22 CISPLATIN + GEMCITABINE N N 220031046 CISPLATIN + GEMCITABINE
220006792 220002611 1.8 61.4 null 2017-10-15 2017-11-10 Cisplatin + Gemcitabine (D 1 & 8) N N 220031046 CISPLATIN + GEMCITABINE
220006793 220002611 1.58 59.7 Palliative (P) 2017-09-20 2017-10-11 Cisplatin + Gemcitabine (D 1 & 8) 02 N 220031046 CISPLATIN + GEMCITABINE
220006794 220002612 1.66 85.9 Disease modification (D) null 2014-09-17 AML18 PILOT TRIAL null Y 220031051 PILOT TRIAL
220006795 220002612 1.52 90.6 Curative (C) 2015-08-04 2015-08-04 AML18 PILOT TRIAL Y N 220031051 PILOT TRIAL
220006796 220002613 150.7 78 Curative (C) null 2015-08-03 AML 18 TRIAL Y N 220031059 AML18 TRIAL
220006797 220002614 1.82 83 Palliative (P) 2015-03-02 2015-03-13 CISPLATIN + GEMCITABINE N N 220031064 CISPLATIN + GEMCITABINE
220006798 220002615 1.79 72.2 Palliative (P) null 2017-09-01 GEMCARBO 02 null 220031065 GEMCARBO
220006799 220011517 1.62 61.8 Palliative (P) 2017-10-28 2017-11-09 Carboplatin + Paclitaxel (3 weekly) N N 220031069 CARBOPLATIN + PACLITAXEL
220006800 220011517 null 87 null 2013-06-21 2013-07-05 GemCarbo Days 1+8 N N 220031069 GEMCARBO
220006801 220018862 null 68.2 Palliative (P) 2014-03-16 2014-03-17 GemCarbo Days 1+8 null N 220031074 GEMCARBO
220006802 220018862 1.62 84 Neo-adjuvant (N) 2013-08-23 2013-08-26 CARBOPLATIN + PACLITAXEL 02 N 220031074 CARBOPLATIN + PACLITAXEL
220006803 220002616 1.85 61.6 Palliative (P) 2015-08-04 2015-08-11 Dasatinib 2 N 220031078 DASATINIB
220006804 220002616 1.64 61.9 null 2017-06-16 2017-07-06 GemCarbo Days 1+8 N N 220031078 GEMCARBO
220006805 220002616 null 52.7 Curative (C) 2013-11-27 2013-12-02 AML18 PILOT TRIAL Y N 220031078 PILOT TRIAL
220006806 220002617 1.9 95 Palliative (P) 2013-06-22 2013-06-29 GemCarbo Days 1+8 N N 220031085 GEMCARBO
220006812 220002619 null 47 Palliative (P) 2015-01-07 2015-01-12 Dasatinib 2 N 220031099 DASATINIB
220006813 220011520 1.67 45.5 Curative (C) null 2018-01-25 AML 18 TRIAL 01 N 220031102 AML18 TRIAL
220006817 220002621 1.56 72 Palliative (P) 2017-05-10 2017-06-13 AML16 DA 3+10 N N 220031114 AML16 TRIAL
220006818 220011522 1.6 58 Curative (C) 2015-03-10 2015-03-10 AML18 PILOT TRIAL 01 N 220031115 PILOT TRIAL
220006819 220011522 1.68 null Curative (C) null 2015-01-01 AML 18 TRIAL Y N 220031115 AML18 TRIAL
220006820 220011522 1.52 null Palliative (P) 2015-09-15 2015-11-02 Cisplatin + Gemcitabine (D 1 & 8) 02 N 220031115 CISPLATIN + GEMCITABINE
220006821 220011522 1.66 74.8 Palliative (P) 2017-06-21 2017-06-22 GemCarbo Days 1+8 02 N 220031115 GEMCARBO
220006822 220002622 null 57.4 Palliative (P) 2015-08-06 2015-08-07 CARBOPLATIN + PACLITAXEL 3 N 220031125 CARBOPLATIN + PACLITAXEL
220006823 220002623 1.7 68.4 Palliative (P) 2015-09-13 2015-09-20 Dasatinib Y N 220031126 DASATINIB
220006824 220002624 1.71 57.1 Palliative (P) 2013-04-06 2013-05-08 AML16 Low Dose Cytarabine 02 Y 220031128 AML16 TRIAL
220006825 220002625 1.55 91.2 Curative (C) null 2017-10-01 AML 18 TRIAL 01 N 220031130 AML18 TRIAL
220006826 220002626 1.6 89.3 Palliative (P) 2014-06-10 2014-07-08 GemCarbo Days 1+8 N N 220031131 GEMCARBO